View Older Stories View More Recent Stories

May 20, 2016 05:22PM Form 4 Corvus Pharmaceuticals, For: May 18 Filed by: ORBIMED ADVISORS LLC
May 20, 2016 04:07PM Form SC 13D Intellia Therapeutics, Filed by: ORBIMED ADVISORS LLC
May 16, 2016 04:45PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 13, 2016 05:10PM Form 4 Intellia Therapeutics, For: May 11 Filed by: ORBIMED ADVISORS LLC
May 2, 2016 08:00AM Graybug Vision Announces $44.5 Million Series B Financing
Apr 27, 2016 08:00AM Critical Outcome Technologies Augments Advisory Board Drug Development Experience
Apr 19, 2016 05:54PM Xtent, Inc. (XTNT) Prelim. Q1 Rev. Misses Consensus
Apr 19, 2016 05:50PM Xtant Medical Pre-Announces First Quarter 2016 Revenue
Apr 19, 2016 05:02PM Form 3 Aeglea BioTherapeutics, For: Apr 12 Filed by: ORBIMED ADVISORS LLC
Apr 18, 2016 03:25PM Form SC 13G Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 13, 2016 10:21AM Form SC 13G/A Biotie Therapies Corp. Filed by: ORBIMED ADVISORS LLC
Apr 12, 2016 04:21PM Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act
Apr 1, 2016 01:11PM Form SC 13D Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 31, 2016 04:45PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Mar 29, 2016 12:21PM Form 4 Corvus Pharmaceuticals, For: Mar 29 Filed by: ORBIMED ADVISORS LLC
Mar 17, 2016 11:57AM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Mar 16, 2016 03:30PM Form SC 13D/A Otonomy, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 16, 2016 07:45AM New Rational Combinations for Immuno-Oncology Conference Announced for NYC Addressing Novel Trial Designs and Business Development Strategies
Feb 16, 2016 04:31PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 16, 2016 03:48PM Form SC 13G/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 02:07PM Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:37PM Form SC 13G/A SYNERGY PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:34PM Form SC 13G IMMUNOMEDICS INC Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:31PM Form SC 13G eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:28PM Form SC 13G DYNAVAX TECHNOLOGIES Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:27PM Form SC 13G ProNAi Therapeutics Inc Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:23PM Form SC 13G/A COGENTIX MEDICAL INC Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 12:18PM Form SC 13G/A Biodel Inc Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 08:11AM Unilife Corp. (UNIS), Amgen (AMGN) Extend Exclusivity Period; Unilife Announces Amendment to Credit Agreement
Feb 16, 2016 06:24AM Form SC 13G/A IRONWOOD PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 16, 2016 06:20AM Form SC 13G/A Cynapsus Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:17PM Form SC 13G/A IMPAX LABORATORIES INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:15PM Form SC 13G Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:12PM Form SC 13G INSMED Inc Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:09PM Form SC 13G/A INFINITY PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 03:06PM Form SC 13G IMMUNOGEN INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:42PM Form SC 13G CONNECTURE INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:40PM Form SC 13G/A CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:37PM Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:34PM Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:29PM Form SC 13G/A ARQULE INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:26PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:23PM Form SC 13G ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Feb 12, 2016 02:14PM Form SC 13G GLAUKOS Corp Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 05:09PM Form SC 13G/A XENOPORT INC Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:55PM Form SC 13G/A Wright Medical Group Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:52PM Form SC 13G/A SINOVAC BIOTECH LTD Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:50PM Form SC 13G/A Sientra, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:44PM Form SC 13G/A ProQR Therapeutics N.V. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:42PM Form SC 13G PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories